Maridomycin V

Maridomycin V

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Antibiotics
Catalog number BBF-02304
CAS 35942-57-5
Molecular Weight 815.94
Molecular Formula C40H65NO16
Purity ≥95%

Online Inquiry

Description

It is produced by the strain of Str. hygroscopicus B-5050. It's a macrolide antibiotic. It has the activity against gram-positive bacteria and mycoplasma. Serum dose not affect its antibacterial activity. It has the effect of protecting gram-positive bacterial infection mice, and the therapeutic dose is similar to styloleomycin.

Specification

Synonyms Antibiotic B 5050E; Turimycin EP2; Leucomycin V, 12,13-dihydro-12,13-epoxy-, 4B-acetate 3-propanoate, (12S,13S)-
IUPAC Name [(1S,3R,7R,8S,9S,10R,12R,13R,14E,16S)-9-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-5-acetyloxy-4-hydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-hydroxy-8-methoxy-3,12-dimethyl-5-oxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-7-yl] propanoate
Canonical SMILES CCC(=O)OC1CC(=O)OC(CC2C(O2)C=CC(C(CC(C(C1OC)OC3C(C(C(C(O3)C)OC4CC(C(C(O4)C)OC(=O)C)(C)O)N(C)C)O)CC=O)C)O)C
InChI InChI=1S/C40H65NO16/c1-11-30(45)55-29-18-31(46)50-21(3)17-28-27(54-28)13-12-26(44)20(2)16-25(14-15-42)36(37(29)49-10)57-39-34(47)33(41(8)9)35(22(4)52-39)56-32-19-40(7,48)38(23(5)51-32)53-24(6)43/h12-13,15,20-23,25-29,32-39,44,47-48H,11,14,16-19H2,1-10H3/b13-12+/t20-,21-,22-,23+,25+,26+,27+,28+,29-,32+,33-,34-,35-,36+,37+,38+,39+,40-/m1/s1
InChI Key QYRBRIAEWVBXAX-LJYLSQHQSA-N

Properties

Antibiotic Activity Spectrum Gram-positive bacteria; Mycoplasma
Boiling Point 879.8°C at 760 mmHg
Melting Point 144-149°C (dec.)
Density 1.26 g/cm3
Solubility Soluble in Ethanol

Reference Reading

1. Analytical studies of maridomycin. II. Separation of 9-propionylmaridomycins by thin-layer chromatography
K Kondo J Chromatogr. 1979 Feb 1;169:337-42. doi: 10.1016/0021-9673(75)85058-8.
Priopionyl derivatives of maridomycins, 9-propionylmaridomycins (PMDMs), are sixteen-membered ring macrolide antibiotics of six analogous components: I, II, III, IV, V and VI. The present paper deals with the separation and quantitative analysis of these components. The analysis was performed by thin-layer chromatographic separation, addition reaction of gaseous iodine with PMDMs on the plate, extraction of the PMDM-iodine complexes, and subsequent analysis of the amount of reacted iodine, using an automatic analysis system. To ascertain the reaction product of this system, PMDM III-iodine complex was synthesized separately under a liquid-phase reaction and the ratio of PMDM III and iodine atoms was determined to be 1:3 on physicochemical examination.

Recommended Products

BBF-05862 Epirubicin Inquiry
BBF-00764 Cerebroside C Inquiry
BBF-02642 Lactonamycin Inquiry
BBF-03754 CASTANOSPERMINE Inquiry
BBF-01825 Loganin Inquiry
BBF-03753 Baicalin Inquiry

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code
cartIcon
Inquiry Basket